Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Ultralife Q4 Adj. EPS $0.18 Beats $0.09 Estimate, Sales $44.55M Beat $39.00M Estimate

Author: Benzinga Newsdesk | February 15, 2024 08:03am

Ultralife (NASDAQ:ULBI) reported quarterly adjsuted earnings of $0.18 per share which beat the analyst consensus estimate of $0.09 by 100 percent. This is a 1900 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $44.55 million which beat the analyst consensus estimate of $39.00 million by 14.23 percent. This is a 23.38 percent increase over sales of $36.11 million the same period last year.

Posted In: ULBI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist